Skip to content

An exploratory study on wet syndrome

An exploratory study on wet syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004602
Enrollment
Unknown
Registered
2021-01-01
Start date
2020-12-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eczema

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Eczema patient group Inclusion criteria: (1)Patients with eczema diagnosed by western medicine; (2)The functions of the heart, liver, lung, kidney and other important organs are basically normal; (3)Participate in this study voluntarily and sign the informed consent form (patients under 18 years old need to be signed by a guardian at the same time). 2. Patients with eczema wet syndrome group Inclusion criteria: (1)Patients with eczema in western medicine and syndrome differentiation in Traditional Chinese medicine meet the criteria for determining wet syndrome; (2)The functions of the heart, liver, lung, kidney and other important organs are basically normal; (3)Participate in this study voluntarily and sign the informed consent form (patients under 18 years old need to be signed by a guardian at the same time). 3. Healthy control group Inclusion criteria: (1)Routine physical examination and stool routine were normal; (2)Regular defecation, no history of diarrhea or other gastrointestinal diseases in the past 1 month; (3)Subjects sign written informed consent to participate in this study (patients under the age of 18 shall be signed by their parents or guardians).

Exclusion criteria

Exclusion criteria: 1. Eczema patient group Exclusion criteria: (1) Metabolic diseases (such as hypertension, diabetes, etc.), cardiovascular and cerebrovascular diseases, Parkinson's disease, infection, malignant tumors, liver/kidney diseases; (2) Gastrointestinal and hepatobiliary inflammatory diseases, gastrointestinal diseases, tuberculosis, parasites, etc.; (3) Special population: pregnant/lactating women, mental patients, etc.; (4) Combined with other skin diseases that need treatment, such as psoriasis, alopecia areata, scabies, etc.; (5) Patients who had received immunosuppressants, microecological preparations, glucocorticoids or antibiotics within 12 weeks. (6) Patients with a history of smoking in half a year. 2. Patients with eczema wet syndrome group Exclusion criteria: (1) Metabolic diseases (such as hypertension, diabetes, etc.), cardiovascular and cerebrovascular diseases, Parkinson's disease, infection, malignant tumors, liver/kidney diseases; (2) Gastrointestinal and hepatobiliary inflammatory diseases, gastrointestinal diseases, tuberculosis, parasites, etc.; (3) Special population: pregnant/lactating women, mental patients, etc.; (4) Combined with other skin diseases that need treatment, such as psoriasis, alopecia areata, scabies, etc.; (5) Patients who had received immunosuppressants, microecological preparations, glucocorticoids or antibiotics within 12 weeks. (6) Patients with a history of smoking in half a year. 3. Healthy control group Exclusion criteria: (1) An individual or his or her immediate family member has a history of allergic diseases, such as asthma, allergic rhinitis, allergic conjunctivitis, urticaria, eczema, etc.; (2) Have taken antibiotics and microecological preparations in the past 1 month; (3) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
EASI;

Secondary

MeasureTime frame
Patient eczema Self-monitoring Scale;Visual Analog Scale;Skin Quality of Life Index questionnaire;(Wet syndrome - eczema) Information Collection table of TCM symptoms;Visual Analog Scale;Chinese Medicine Wet syndrome Evaluation Scale;

Countries

China

Contacts

Public ContactDacan Chen

Guangdong Provincial Hospital of Traditional Chinese Medicine

4910702@163.com+86 13602864954

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026